Trial Profile
A double-blind, randomized, parallel group trial of Ditropan XL (oxybutynin chloride) extended release tablets or placebo in combination with Flomax (tamsulosin hydrochloride) for the treatment of lower urinary tract symptoms
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Oxybutynin (Primary) ; Tamsulosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- Sponsors McNeil Consumer Pharmaceuticals
- 02 Dec 2006 New trial record.